0 distinct strategies that cleared the lab.
Of 229,896 strategies the lab has tested, 1814 gene variants graduated, but those collapse to 0 distinct entry rules once you de-duplicate take-profit grid-search variants. Of those, 0 are live-traded today, 0 survived walk-forward + Deflated Sharpe + cost modeling + regime-conditional edge, and 0 are provisional candidates with zero validation trades.
One row per distinct entry rule below. We keep the highest-Sharpe parameter variant of each so the page isn't 1,000 near-identical cards. The full 1,814-gene corpus is what the live engine selects from in real time; this page is the human-readable summary.
Have a strategy you want to test against the same gates?
Paste it on /prove. Same engine, same fees, same walk-forward validation. Free, no signup. If yours passes, it could end up on this page.
One new survivor strategy a week, plus our monthly live-trading review.
No spam. Unsubscribe in one click. We send what works and what didn't.
Each candidate was tested across multiple coins on Binance with real per-coin L2 spread samples, slippage calibrated against forward-test data, and the Deflated Sharpe Ratio adjusted for the full 229,896-candidate testing universe. Tiers reflect lab state: Live-traded entries are in the forward-test engine, walk-forward survivors passed all six gates with auditable backtest trades, and provisional candidates are in the pipeline with zero validation trades. We do not cherry-pick backtest periods. Exact configurations are paywalled so $10 buyers receive genuinely actionable strategies. Backtests are simulations; live markets behave differently. For educational and research purposes only.